Sanofi Stock Euronext Paris
Stocks
SANNV
FR001400M6Z3
Pharmaceuticals
OTC Markets Traded| Market Cap | 94.58B 110B 88.49B 81B 152B 10,564B 154B 1,046B 408B 5,307B 415B 406B 17,552B | P/E 2026 * |
12.6x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 106B 124B 99.21B 90.82B 170B 11,843B 173B 1,172B 457B 5,950B 465B 455B 19,679B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 2.03x |
| Free-Float |
88.34% | Yield 2026 * |
5.39% | Yield 2027 * | 5.7% |
Last Transcript: Sanofi
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 110B | |
| -1.06% | +4.84% | +78.40% | +126.36% | 1,119B | |
| +1.20% | +4.12% | +53.12% | +65.47% | 651B | |
| -0.25% | +5.36% | +27.08% | +79.88% | 468B | |
| -1.38% | +4.02% | +42.52% | +42.38% | 374B | |
| -0.52% | +2.72% | +25.21% | +41.06% | 302B | |
| -1.06% | +4.76% | +2.00% | +12.65% | 259B | |
| +0.45% | +5.16% | +52.88% | +71.86% | 238B | |
| -0.53% | +2.34% | -18.53% | -53.66% | 208B | |
| -0.12% | +4.91% | +27.67% | +90.93% | 181B | |
| Average | -0.36% | +5.17% | +32.26% | +52.99% | 422.21B | |
| Weighted average by Cap. | -0.43% | +5.40% | +45.46% | +72.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.59B 55.56B 44.53B 40.76B 76.5B 5,316B 77.51B 526B 205B 2,670B 209B 204B 8,833B | 50.7B 59.18B 47.44B 43.42B 81.49B 5,663B 82.57B 560B 219B 2,845B 222B 217B 9,409B |
| Net income | 7.91B 9.24B 7.4B 6.78B 12.72B 884B 12.88B 87.45B 34.1B 444B 34.68B 33.92B 1,468B | 9.24B 10.79B 8.65B 7.92B 14.86B 1,032B 15.05B 102B 39.85B 519B 40.52B 39.64B 1,716B |
| Net Debt | 11.46B 13.37B 10.72B 9.81B 18.42B 1,280B 18.66B 127B 49.39B 643B 50.22B 49.13B 2,126B | 8.3B 9.69B 7.77B 7.11B 13.35B 927B 13.52B 91.8B 35.8B 466B 36.4B 35.61B 1,541B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
